The Canadian government agency Health Canada issued a reminder to hospitals
last fall on the risk of entrapment of patients in hospital beds. This
notice raises again what should by now be a well known hazard.
The short-acting, reversible anticoagulant heparin is widely used in hospitalized patients to prevent the development or extension of potentially life-threatening blood clots. However, numerous issues make the use of this high-risk agent particularly challenging and error-prone.